Description
CJC-1295 (Without DAC) + Ipamorelin is a complementary peptide combination developed for research and formulation use focused on studying growth hormone-related signaling pathways and normal endocrine communication.
This pairing brings together two short-acting peptides that interact with distinct but complementary receptors, allowing for coordinated signaling without long-term receptor binding. The non-DAC form of CJC-1295 is intentionally short-lived, making it suitable for applications where controlled, transient activity is preferred.
The combination is widely referenced in laboratory and investigational contexts exploring pulsatile peptide signaling.
ATTENTION: All Unique ChemX products featured here are intended exclusively for research and development purposes. They are not designed for any form of human or animal consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.
